Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 8 of the 41 sources its claims cite were checked for support.
Abstract
Beta (β)-cell senescence contributes to type 2 diabetes mellitus (T2DM). While exercise is vital for T2DM management and significantly affects cellular ageing markers, its effect on β-cell senescence remains unexplored. Here, we show that short-term endurance exercise training (treadmill running, 1 h per day for 10 days) in two male and female mouse models of insulin resistance decreases β-cell senescence. In vivo and in vitro experiments revealed that this effect is mediated, at least in part, by training-induced increases in serum glucagon, leading to activation of 5'-AMP-activated protein kinase (AMPK) signalling in β-cells. AMPK activation resulted in the nuclear translocation of NRF2 and decreased expression of senescence markers and effectors. Remarkably, human islets from male and female donors with T2DM treated with serum collected after a 10-week endurance exercise training programme showed a significant decrease in the levels of senescence markers. These findings indicate that exercise training decreases senescence in pancreatic islets, offering promising therapeutic implications for T2DM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 1 Not valid · 23 Not checked · 106 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“but decreased p16Ink4a mRNA levels, a marker of late senescence, by 73% (Fig. 2i)”
§ Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence > Results > Prevention of β-cell senescence outweighs its reversal
What the sources say
- Disputedcites [22] Midha, A. et al. Unique human and mouse β-cell senescence-associated secretory phenotype (SASP) reveal conserved signaling pathways and heterogeneous factors. Diabetes 70, 1098–1116 (2021). sourceExperimental — accuracy not yet measured
Our copy contains no exercise intervention at all: the 'reversal' condition is a 2-week recovery after S961 insulin-receptor-antagonist pumps were removed in C57BL6/J mice (Acute Insulin Resistance Altered β-Cell Expression of SASP Signature Genes; Single-Cell RNA-seq of β-Cells From Insulin-Resistant Mice). More directly contrary, that section states that transcriptional expression of Cdkn2a (p16Ink4a) 'increased in the S961 group and increased even further in the recovery group (Fig. 3F)', and the Discussion frames Cdkn2a as persisting rather than reversing — the opposite of a 73% fall in p16Ink4a mRNA in the reversal group. The reversible markers in this paper are Cdkn1a/p21 and the SASP signature genes, not p16Ink4a, and no 73% figure appears anywhere in our copy. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
- Could not verifycites [23] De Cecco, M. et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566, 73–78 (2019). sourceExperimental — accuracy not yet measured
Our copy of De Cecco et al. (2019) contains no exercise-training or 'reversal' experiment at all: every intervention it reports is genetic (L1 shRNA; the RB1-knockdown/TREX1/FOXA1 '3X' combination, Fig. 2d–h, Extended Data Fig. 5) or pharmacological (3TC and other NRTIs, K-9; Extended Data Figs. 5, 7, 9), in cultured human fibroblasts or old mice, and no passage gives a 73% change in p16Ink4a mRNA. The closest p16 statement is that in old mice 3TC left 'Expression of L1 mRNA and p16 ... weakly downregulated, but in most cases did not reach statistical significance' (Activation of L1 in human and mouse tissues), and p16 appears only as a senescence marker in immunofluorescence/immunoblot assays (Extended Data Figs. 1c, 8). Searched: 'p16Ink4a mRNA levels 73%', 'Fig. 2i p16', 'reversal of senescent phenotype', 'exercise training physical activity', 'CDKN2A mRNA senescent versus 3X cells'; the only supportable fragment is that p16 is a senescence marker, not the quantitative exercise result the sentence attributes to this source. (LLM, conf=0.70)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“An increase in the levels of LKB1 (liver kinase B1, STK11)30, an upstream kinase of AMPK31, was observed in the trained group (Fig. 3d,h)”
§ Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence > Results > Exercise training activates AMPK in pancreatic islets
What the sources say
- Supportedcites [30] Kari, S., Vasko, V. V., Priya, S. & Kirschner, L. S. PKA activates AMPK through LKB1 signaling in follicular thyroid cancer. Front. Endocrinol. (Lausanne) 10, 769 (2019). source
In the citing sentence, reference 30 is attached to the naming gloss 'LKB1 (liver kinase B1, STK11)', not to the trained-group measurement (which the citing authors report as their own data, Fig. 3d,h). Our copy performs exactly that identification: the Discussion states 'The serine-threonine kinase LKB1 (STK11) is mutated in the tumor predisposition Peutz-Jeghers syndrome', and the Results repeatedly treat LKB1 as the upstream kinase that phosphorylates/activates AMPK ('LKB1 is the major kinase responsible for AMPK activation downstream of PKA'; 'LKB1 not only activates AMPK but 13 other AMPK-like kinases'). Searched our copy for exercise/training content (exercise training, physical activity, skeletal muscle) — none exists, consistent with the fact that the exercise result is not what this citation is offered for. (LLM, conf=0.80)
- Not checked yetcites [31] Witters, L. A., Kemp, B. E. & Means, A. R. Chutes and ladders: the search for protein kinases that act on AMPK. Trends Biochem. Sci 31, 13–16 (2006). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The beneficial effects of exercise on β-cells apply to both type 1 diabetes and T2DM20 and should be considered an additional therapeutic pathway.”
§ Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence > Discussion > Study limitations
What the sources say
- Supportedcites [20] de Brachène, A. C. et al. Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes. Diabetologia 66, 450–460 (2023). source
The Discussion reports that serum from exercised participants with type 1 or type 2 diabetes protected beta cells against ER stress and proposes testing exercise to protect beta cells in people at risk of either disease. The evidence is from serum-tested human beta cells; the paper does not claim that clinical beta-cell protection has been established. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As β-gal is not required for senescence40”
§ Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence > Discussion
What the sources say
- Supportedcites [40] Lee, B. Y. et al. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging Cell 5, 187–195 (2006). source
The Discussion explicitly states that SA-β-gal activity is not required for senescence: cells underwent senescence despite GLB1 knockdown and substantially reduced SA-β-gal activity. The cited claim is a concise paraphrase of that finding. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and improved peripheral insulin sensitivity, as revealed by the ITT (Fig. 2m)”
§ Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence > Results > Senolytic effects of exercise training
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
75 more claims
Create a free account to see all 136 claims and to verify the 33 references still open.
- Probably not a substantial claim. 27
- It may state two separate claims as one. 32
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“we leveraged our previously established SenMayo gene set (Saul et al, 2022), which has been demonstrated to be commonly regulated across various age-related transcriptome datasets and is primarily composed of SASP-related factors (Brizio et al, 2024; Carapeto et al, 2024; Suryadevara et al, 2024).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Carapeto et al, 2024
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence > Abstract
“human islets from male and female donors with T2DM treated with serum collected after a 10-week endurance exercise training programme showed a significant decrease in the levels of senescence markers.”
§ Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence > Extended Data
“Table: Extended Data Table 1 ∣ Donor information for human pancreatic samples | Age (years) | T2D | BMI | Applications | | --- | --- | --- | --- | | 54 | NO | 24.5 | Serum treatment, WB, FACS, qPCR | | 45 | NO | 21.9 | Serum treatment, WB, FACS, qPCR |”
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“T2DM is characterized by accelerated cellular ageing, as shown by an increase in biochemical changes that underlie the progressive loss of tissue integrity and function, collectively known as the hallmarks of ageing 6 .”
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109119 · Cited by 10,123
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends
Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2019) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.191028.001 · Cited by 3,130
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444
L1 drives IFN in senescent cells and promotes age-associated inflammation
De Cecco, M., Ito, T., Petrashen, A. P., Elias, A. E., Skvir, N. J., Criscione, S. W., Caligiana, A., Brocculi, G., Adney, E. M., Boeke, J. D., et al. (2019) · Nature · doi:10.1038/s41586-018-0784-9 · Cited by 1,255 · cited 3×
“Previous data have suggested that p16Ink4a is involved in maintaining senescence, whereas p21Cip1 is involved in establishing senescence 23,39 .”
Salomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61690-0 · Cited by 1,116
A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
Saul, D., Kosinsky, R. L., Atkinson, E. J., Doolittle, M. L., Zhang, X., LeBrasseur, N. K., Pignolo, R. J., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32552-1 · Cited by 1,022 · cited 1×
“The analysis included the SenMayo dataset, which lists a collection of genes commonly upregulated in senescent cells across tissues 24 .”
Stein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868 · cited 1×
“Previous data have suggested that p16Ink4a is involved in maintaining senescence, whereas p21Cip1 is involved in establishing senescence 23,39 .”
Cited by
AMPK at the interface of nutrient sensing, metabolic flux and energy homeostasis
Smith, T. K. T., Townsend, L. K., Smiles, W. J., Oakhill, J. S., Fullerton, M. D., & Steinberg, G. R. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01442-3 · Cited by 65
Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues
Saul, D., Jurk, D., Doolittle, M. L., Kosinsky, R. L., Han, Y., Zhang, X., Franco, A. C., Kim, S. Y., Wyles, S. P., Prakash, Y. S., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00601-2 · Cited by 45
Deep single-cell decoding of human pancreatic islets reveals T2D β-cell gene expression defects
Bandesh, K., Motakis, E., Nargund, S., Kursawe, R., Selvam, V., Ansarullah, Bhuiyan, R. M., Eryilmaz, G. N., Willett, A., White, J. K., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00744-w · Cited by 30
Wang, J., He, Y., Wang, Z., Wang, Z., Miao, Y., & Choi, J.-Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1663560 · Cited by 20
Costa-Júnior, J. M., de Brachène, A. C., Musuaya, A., Zimath, P. L., Martín-Vázquez, E., Oliveira, J. G., Carpentier, J., Faoro, V., Klass, M., Cnop, M., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06426-2 · Cited by 16
Metadata
- Authors
- Carapeto, P., Iwasaki, K., Hela, F., Kahng, J., Alves-Wagner, A. B., Middelbeek, R. J. W., Hirshman, M. F., Rutter, G. A., Goodyear, L. J., & Aguayo-Mazzucato, C.
- Affiliations
- Joslin Diabetes Center (US)
- Nanyang Technological University (SG)
- ORCID
- Venue
- Nature Metabolism
- Published
- 2024-09-24
- Volume
- 6
- Issue
- 10
- Pages
- 1976-1990
- ISSN
- 2522-5812 (ISSN-L)
- PMC
- PMC12005094
- OpenAlex
- W4402769604
- Cited by
- 35
- References
- 49
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 1
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DR-NTU (Nanyang Technological University) (submittedVersion)
- Funders
- American Diabetes Association (1-17-PMF-009, MR/R022259/1)
- Richard and Susan Smith Family Foundation
- Joslin Diabetes Center (P30DK036836, DK036836)
- Wellcome Trust (R022259, 212625/Z/18/Z)
- Boston Area Diabetes Endocrinology Research Center
- Diabetes UK (BDA 16/0005485)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Novo Nordisk
- National Institutes of Health (2r25dk113652-06, SCR_014387, DK036836, 1R25DK113652, 5r01dk112283-03)
- Canadian Institutes of Health Research
- Medical Research Council (MR/K001981/1, MR/R022259/1, MR/R014329/1)
- Biotechnology and Biological Sciences Research Council (BB/J015873/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK112283, UC4DK098085, DK036836, K23DK114550, SCR_014387, R25 DK113652, R01DK135268, P30DK036836, R01DK099511, R01DK132535)
- Breakthrough T1D Canada (4-SRA-2023-1382-S-N)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- exercise training, AMPK, β-cell senescence, pancreatic islets, type 2 diabetes, endurance exercise, glucagon, Nrf2 nuclear translocation, insulin resistance, cellular aging, senescence markers
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Enzyme Activation, Female, Glucagon, Humans, Insulin Resistance, Islets of Langerhans, Male, Physical Conditioning, Animal, Signal Transduction, Cellular Senescence, Insulin-Secreting Cells, NF-E2-Related Factor 2, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence. https://app.cochat.ai/papers/10.1038/s42255-024-01130-8
- The paper
- Carapeto, P., Iwasaki, K., Hela, F., Kahng, J., Alves-Wagner, A. B., Middelbeek, R. J. W., Hirshman, M. F., Rutter, G. A., Goodyear, L. J., & Aguayo-Mazzucato, C. (2024). Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence. Nature Metabolism. https://doi.org/10.1038/s42255-024-01130-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.